The global impact and cost-effectiveness of a melioidosis vaccine

The global impact and cost-effectiveness of a melioidosis vaccine

Abstract Background Every year, 90,000 people may die from melioidosis. Vaccine candidates have not proceeded past animal studies, partly due to uncertainty around the potential market size. This study aims to estimate the potential impact, cost-effectiveness and market size for melioidosis vaccines...

Full description

Bibliographic Details
Main Authors: Nantasit Luangasanatip, Stefan Flasche, David A. B. Dance, Direk Limmathurotsakul, Bart J. Currie, Chiranjay Mukhopadhyay, Tim Atkins, Richard Titball, Mark Jit
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Medicine
Subjects:
Melioidosis
Infections
Vaccine
Cost-effectiveness
Economic evaluation
Online Access:http://link.springer.com/article/10.1186/s12916-019-1358-x

Internet

http://link.springer.com/article/10.1186/s12916-019-1358-x

Similar Items